Berinert® (C1-Esterase Inhibitor Concentrate) Treatment Is Not Related to Prothrombotic Risk Based On Preclinical Efficacy and Safety Investigations

被引：2
|
作者：
Herzog, Eva [1 ]
Schuermann, Daniel [1 ]
Raquet, Elmar [1 ]
Zollner, Sabine [1 ]
Pragst, Ingo [1 ]
机构：
[1] CSL Behring GmbH, Marburg, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.1063
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB109 / AB109
页数：1
相关论文
共 50 条
  • [1] C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk
    Schuermann, Daniel
    Herzog, Eva
    Raquet, Elmar
    Nolte, Marc W.
    May, Frauke
    Mueller-Cohrs, Jochen
    Bjorkqvist, Jenny
    Dickneite, Gerhard
    Pragst, Ingo
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (05) : 960 - +
  • [2] Human C1-Esterase Inhibitor Concentrate (Berinert®)
    Keating, Gillian M.
    BIODRUGS, 2009, 23 (06) : 399 - 406
  • [3] Human C1-Esterase Inhibitor Concentrate (Berinert®)
    Gillian M. Keating
    BioDrugs, 2009, 23 : 399 - 406
  • [4] Assessment of Inhibitory Antibody Formation in Subjects with Hereditary Angioedema Treated with Plasma-Derived C1-Esterase Inhibitor Concentrate (Berinert®)
    Farkas, Henriette
    Moldovan, Dumitru
    ObtuA, Krystyna Owicz
    Shirov, T.
    Edelman, Jonathan M.
    Williams-Herman, Debora
    Rojavin, Mikhail
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB247 - AB247
  • [5] EFFICACY AND SAFETY OF C1 ESTERASE INHIBITOR CONCENTRATE (BERINERT®) FOR THE TREATMENT OF ACUTE HEREDITARY ANGIOEDEMA IN OBESE VS. NON-OBESE PATIENTS
    Bernstein, J. A.
    Craig, T. J.
    Keinecke, H.
    Machnig, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A99 - A100
  • [6] Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema:: a review
    De Serres, J
    Gröner, A
    Lindner, J
    TRANSFUSION AND APHERESIS SCIENCE, 2003, 29 (03) : 247 - 254
  • [7] Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient Registry
    Busse, Paula
    Bygum, Anette
    Edelman, Jonathan
    Lumry, William
    Machnig, Thomas
    Martinez-Saguer, Inmaculada
    Rojavin, Mikhail
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (02): : 213 - 219
  • [8] Association of C1 Esterase-Inhibitor Functional Activity and Treatment Response With C1 Esterase-Inhibitor Concentrate (Berinert®) for Acute Attacks of Hereditary Angioedema
    Bewtra, A. K.
    Hurewitz, D. S.
    Bernstein, J. A.
    Machnig, T.
    Keinecke, H.
    Craig, T. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB223 - AB223
  • [9] Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: A systematic literature review
    Bork, Konrad
    Steffensen, Isabella
    Machnig, Thomas
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (04) : 312 - 327
  • [10] Safety of a C1 Esterase Inhibitor Concentrate in Pregnant Women with Hereditary Angioedema: Findings from the International Berinert Patient Registry
    Fox, James A.
    Martinez-Saguer, Inmaculada
    Vegh, Arthur B.
    Wuillemin, Walter A.
    Edelman, Jonathan M.
    Williams-Herman, Debora
    Rojavin, Mikhail
    Rosenberg, Tanja
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB243 - AB243
12345